The Founders of EUBREAST

EUBREAST is a voluntary association of highly experienced oncological breast surgeons. Their focus is directed on improving and de-escalating breast cancer treatment wherever possible based on cross-border trials. The only target of clinical trials conducted by EUBREAST is the ultimate benefit of breast cancer patients.

Founding Members:

Prof. Dr. med.  Thorsten Kühn

Prof. Dr. med. Thorsten Kühn, 

Klinikum Esslingen, Germany 


Chairman of EUBREAST




„Our goal is to transfer scientific progress to clinical practice much faster and to offer our patients less extensive breast cancer surgery.“

Dott. Oreste Gentilini

Dott. Oreste Gentilini

San Raffaele Hospital Milan, Italy


Vice-Chairman of EUBREAST




„As physicians, we are convinced that European networking of capable scientists and experts is highliy advantageous for our patients.”

Univ. Prof. Priv. Doz. Dr. Florentia Peintinger

Univ. Prof. Priv. Doz. Dr.

Florentia Peintinger

Medical University Graz

& Leoben General Hospital, Austria


Treasurer of EUBREAST




„We promote clinical expertise and pathways of scientific intelligence in an international context to optimize breast cancer treatment.“

Ass. Prof. Jana de Boniface, 

Ass. Prof.

Jana de Boniface, 

Karolinska Insitutet, Capio St. Göran’s Hospital, Stockholm, Sweden




 „Breast cancer is a complex disease requiring large-scale cross-disciplinary and cross-border research structures to promote individualised treatment and define the crucial equilibrium between benefit and harm of locoregional treatment. Collaborative research has great potential to unify fragmented European perspectives on breast cancer management to the benefit of all European women.“

Pr. Jean-Marc Classe

Pr. Jean-Marc Classe, MD, PhD

Institut de Cancérologie de l’Ouest, Saint-Herblain, Nantes, France



Prof. Dr. Isabel T. Rubio Clinica Universidad  de Navarra, Madrid Spain

Prof. Dr. Isabel T. Rubio

Clinica Universidad 

de Navarra, Madrid Spain




„Clinical trials have answered questions that changed the way we perform breast surgery today. We have the commitment to keep breast surgical research ongoing cooperating with other groups to be more efficient. Results from these studies will change the way we treat patients in the future. 

Prof. Dr. med.  Toralf Reimer,  University of Rostock,  Germany

Prof. Dr. med. 

Toralf Reimer, 

University of Rostock, Germany



Priv.-Doz. Dr. Roland Reitsamer

Univ.Prof. Dr. Roland Reitsamer
Paracelsus Medical University Salzburg




„Breast surgery, yet the main issue in breast cancer treatment, can be de-escalated and standardized. Morbidity can be reduced without safety compromise. EUBREAST is the path to achieve this goal in the near future.“

Prof. Dr. med.  Thorsten Kühn

Prof. Marjolein L. Smidt
MD, PhD Maastricht University Medical Center, The Netherlands




"In this era of in general good breast cancer survival, attention is warranted for reducing morbidity caused by the extensive universal treatment package deals. Reducing morbidity can be achieved by omission of treatments which no longer benefit the patient."